RK

Rajender Kumar

Director Director DIN 02145121
DIN 02145121 First appointment Mar 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2008
Shareholding value •••• Premium profile

About Rajender Kumar

Data last updated:

Rajender Kumar was a Director at Abc Medico Private Limited (2008–2017) and Director at Skytech Pharma Private Limited (2009–2015). The companies operate in Pharma.

DIN 02145121
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abc Medico Private Limited U01122DL1996PTC079494
Director31 Mar 20081996Strike Off
Skytech Pharma Private Limited U24233DL2004PTC127312
Director09 Jan 20092004₹16.19 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Abc Medico Private Limited
Skytech Pharma Private Limited
Premium access

Shareholding and investment profile for Rajender Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajender Kumar

Rajender Kumar was first appointed on 31 Mar 2008 as Director at Abc Medico Private Limited. The most recent appointment on record is 09 Jan 2009 at Skytech Pharma Private Limited.

Rajender Kumar held 2 earlier board appointments: Abc Medico Private Limited (Director, 31 Mar 2008 to 27 Jul 2017); Skytech Pharma Private Limited (Director, 09 Jan 2009 to 11 Dec 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available